Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study

被引：0
|
作者：
Nawaz, Ahmad [1 ]
Almasaid, Sharifeh [1 ]
Shah, Ayushi [1 ]
Hussain, Azhar [1 ]
Chaar, Abdelkader [1 ]
Patel, Shanti [2 ]
Khalid, Fatima [3 ]
Hayat, Umar [4 ]
Singh, Kelita [1 ]
Aswath, Ganesh [1 ]
Khan, Hafiz Muzaffar Akbar [1 ]
机构：
[1] SUNY Syracuse, Upstate Med Univ, Syracuse, NY USA
[2] Yale New Haven Hosp, New Haven, CT USA
[3] Fatima Mem Hosp, Lahore, Punjab, Pakistan
[4] Geisinger Wyoming Valley Med Ctr, Wilkes Barre, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001035020.13797.dd
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1413
引用
收藏
页码：S1011 / S1012
页数：2
相关论文
共 50 条
  • [1] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [2] Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes
    Bazzani, Chiara
    Filippini, Matteo
    Caporali, Roberto
    Bobbio-Pallavicini, Francesca
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Gorla, Roberto
    AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 260 - 265
  • [3] PPIs and anti-TNF in patients with IBD: a forbidden combination?
    Wellens, Judith
    Sabino, Joao
    Vermeire, Severine
    GUT, 2021, 70 (12) : 2397 - +
  • [4] Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy
    Khadija H. Chaudrey
    Sunanda V. Kane
    Current Treatment Options in Gastroenterology, 2015, 13 (1) : 77 - 89
  • [5] A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD
    Elias, Evan D.
    Targownik, Laura E.
    Singh, Harminder
    Bernstein, Charles N.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 150 - 157
  • [6] VITAMIN D DEFICIENCY IN A COHORT OF IBD PATIENTS TREATED WITH ANTI-TNFα THERAPY
    Parris, C. R.
    Gaya, D. R.
    Winter, J.
    Munro, J.
    Morris, A. J.
    GUT, 2012, 61 : A167 - A167
  • [7] Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy
    Moens, A.
    van der Woude, C.
    Julsgaard, M.
    Sebastian, S.
    Arebi, N.
    Alzinaty, M.
    Humblet, E.
    Kok, K. B.
    Sheridan, J.
    De Saint-Joseph, C. Gilletta
    Nancey, S.
    Rahier, J. -F.
    Bossuyt, P.
    Cremer, A.
    Dewit, S.
    Eriksson, C.
    Hoentjen, F.
    Krause, T.
    Louis, E.
    Macken, E.
    Milenkovic, Z.
    Nijs, J.
    Posen, A.
    Van Hootegem, A.
    Van Moerkercke, W.
    Vermeire, S.
    Shitrit, A. Bar-Gil
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S41 - S42
  • [8] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Kumar, Manoj
    Murugesan, Selvasankar
    Ibrahim, Nazira
    Elawad, Mamoun
    Al Khodor, Souhaila
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [9] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Manoj Kumar
    Selvasankar Murugesan
    Nazira Ibrahim
    Mamoun Elawad
    Souhaila Al Khodor
    Journal of Translational Medicine, 22
  • [10] The impact of anti-TNF therapy on the nonspecialist
    Mandell, Brian F.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 81 (02) : 71 - 72
12345